At a glance
ClinicalIndex Comparison RecordN/ACompleted· 24 enrolled
Drug / intervention
Olanzapine +1 moredrug
Likely dose
Olanzapine 5mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Metabolic Effects of Olanzapine in Healthy Males
In Brief
A clinical study evaluating Olanzapine and Placebo for Healthy. Completed, enrolled 24 participants across 1 site.
Detailed Summary
The purpose of this study is to look at how a two-week use of a medication called Olanzapine might change appetite, physical activity, resting metabolic rate, body composition, and weight in healthy men.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHealthy
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartOct 2007
First PostedDec 2011
Primary CompletionApr 2013
TodayJul 2026
First PostedDec 21, 2011
Enrollment StartOct 1, 2007
Primary CompletionApr 1, 2013
TodayJul 2, 2026
Enrollment to primary: 5.5 yearsPosted 14.5 years ago
Interventions
Olanzapinedrug
Olanzapine 5mg capsule administered orally at bedtime for 7 days followed by Olanzapine 10 mg capsule administered orally at bedtime for 7 days.
Placebodrug
Placebo capsule administered orally at bedtime for 14 days